JP Stock MarketDetailed Quotes
2160 GNI Group
- 2162
- 00.00%
20min DelayMarket to Open May 23 15:00 JST
107.84BMarket Cap13.06P/E (Static)
0High0Low0Volume0Open2162Pre Close0.00Turnover386552wk High0.00%Turnover Ratio49.88MShares107352wk Low193.62EPS TTM101.77BFloat Cap4070Historical High13.06P/E (Static)47.07MShs Float13Historical Low165.56EPS LYR0.00%Amplitude--Dividend TTM3.12P/B100Lot Size--Div YieldTTM
About GNI Group Company
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
Company Profile
Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees720
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Ying Luo, PhD
- Director, Representative Executive Officer, President and Chief Executive Officer
- --
- Thomas Eastling
- Director and Representative Executive Officer
- --
- Sekitani Kazuki
- Director, Vice Chairman, Executive Officer, Head of Organization and Human Resources Headquarters, and Head of Risk Management Center
- --
- Ryosuke Matsui
- Director
- --
- Kikuchi Kanako
- Director
- --
- Hideaki Sashiwa
- Independent Director
- --
- Professor Kan-ichiro Suzuki, PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
%Chg